Provention Plans Two-Phase Launch Of Tzield, Pricing Drug Higher Than Expected

 
• By Alaric DeArment
  
Provention won FDA approval for Tzield, its drug to delay onset of stage 3 type 1 diabetes • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip